Slough's Indivior reports increased revenue in H1 2023 results

International investment company Indivior, a business with offices in Slough, has released its H1 and Q2 financial results for 2023.

The company reported that it had made $276 million in Net Revenue in Q2 this year, a 25 per cent increase on the $221 million posted in the same report last year.

H1 2023 revenue was $529 million, a 24 per cent increase on the $428 million reported in the same are in H1 2022.

Visit Hampshire Biz News for bright, upbeat and positive business news from the county

Net income was down by seven per cent in H1 2023, going from $89 million in H1 2022 to $83 million. With this being said, the company also posted a one per cent increase in operating profit in this year's H1, going from $117 million to $118 million.

Mark Crossley, CEO of Indivior PLC, said: "This has been another strong quarter of financial results and delivery against our strategic priorities, and I would like to thank our teams for their unwavering dedication to our patients.

''The growth of SUBLOCADE (buprenorphine extended release) continues as we further increased the depth of prescribing in Organized Health Systems (OHS), in line with our strategy, and reached a major milestone of over 100,000 U.S. SUBLOCADE patients.

''Our progress in the first six months and positive expectations for the remainder of the year support an increase to our guidance for 2023, and further reinforce our confidence in our attractive medium-term profitable growth aspirations."

Read more - St James Place reports rise in funds under management despite drop in profits